by bureau Peppr | 17 January, 2025 | News
Successful IGJ inspection completed We are proud to share that last week BioConnection successfully completed a three-day inspection by the Healthcare and Youth Inspectorate (IGJ), conducted on behalf of the European Medicines Agency (EMA). This result confirms our...
by bureau Peppr | 7 October, 2024 | News
BioConnection Receives European CMO of the Year Award 2024 in (Bio)pharmaceuticals BioConnection is excited to share that we’ve been named the European Company of the Year in Biopharmaceutical Contract Manufacturing 2024 by Pharma Tech Outlook. This award means a...
by bureau Peppr | 2 September, 2024 | News
Oss, NL September 2, 2024 We are excited to announce that Richard Sewalt has joined BioConnection as our new Chief Commercial Officer (CCO). With his extensive background and proven expertise, Richard will be a key driver of our continued success and growth. Richard...
by bureau Peppr | 26 August, 2024 | News
Oss, NL August 26, 2024 BioConnection is pleased to announce the appointment of Dr. Gary M. Phillips as the new Chairman of the Supervisory Board. Dr. Phillips will succeed Rob Prins in this role. Dr. Gary M. Phillips brings over three decades of experience in the...
by bureau Peppr | 22 May, 2024 | News
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and BioConnection, a specialized contract manufacturing organization (CMO) focusing on aseptic filling of vials and syringes for clinical and commercial...
by bureau Peppr | 13 September, 2023 | News
BioConnection congratulates BioLineRx with their FDA approval of Aphexda. We are proud that we have been able to support BioLineRx since the start of the Motixafortide BL-8040 project (and even before) and be their proud partner through all the clinical phases. It is...
